Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000 sq ft cGMP facility in Belgium and add an additional 10,000 sq ft at their existing facility in Waterford, Ireland. The expansions will be completed in the first half of 2023.
Are you joining us at stability studies 2022? This year, we are looking forward to our first ever Stability Studies conference with a full line-up of pharmaceutical industry experts. Joining us at the conference as a guest speaker is Ken O’Shea, Founder and Managing Director of Qbd Pharma Solutions and Co-founder and CTO of new precision nutrition start-up Reso Health.
This year, we are excited to introduce our first ever Stability Studies conference. Join us at the Killashee Hotel, Naas on Thursday 13th October 2022 to hear experts from the pharmaceutical industry share their tips on evaluating and managing stability studies.
